| Cited in | Search | Type: | Patent literature | Publication No.: | US2005203114
[A] (ARMISTEAD DAVID M et al.) | Type: | Patent literature | Publication No.: | US6878697
[Y] (METCALF III CHESTER A et al.) | Type: | Patent literature | Publication No.: | WO2006078846
[A] (RIGEL PHARMACEUTICALS INC et al.) | Type: | Patent literature | Publication No.: | WO2005016528
[Y] (IRM LLC et al.) | Type: | Patent literature | Publication No.: | WO2007006926
[A] (SANOFI AVENTIS et al.) | Cited in | International search | Type: | Patent literature | Publication No.: | US2005203114
[Y] (ARMISTEAD DAVID M et al.) [Y] | Type: | Patent literature | Publication No.: | US6878697
[Y] (METCALF III CHESTER A et al.) [Y] | Type: | Patent literature | Publication No.: | US6770652
[Y] (GANGJEE ALEEM et al.) [Y] | Cited in | Examination | Type: | Patent literature | Publication No.: | WO2007021937
| Type: | Patent literature | Publication No.: | FR2911138
| Type: | Patent literature | Publication No.: | WO2004080980
| Cited in | Opposition | Type: | Patent literature | Publication No.: | US2005203114
| Type: | Patent literature | Publication No.: | US2004242611
| Type: | Patent literature | Publication No.: | WO2006078846
| Type: | Patent literature | Publication No.: | WO2005016528
| Type: | Patent literature | Publication No.: | WO2007006926
| Type: | Patent literature | Publication No.: | WO2007021937
| Type: | Patent literature | Publication No.: | FR2911138
| Type: | Patent literature | Publication No.: | WO2004080980
| Type: | Non-patent literature | Publication information: | GALKIN ET AL.: "Identification of NVP-TAE684, a potent, selective and efficacious Inhibitor of NPM-ALK", PNAS, vol. 104, no. 1, 2 January 2007 (2007-01-02), pages 270 - 275, XP002661293 | DOI: | http://dx.doi.org/10.1073/PNAS.0609412103 | Type: | Non-patent literature | Publication information: | BRUNING ET AL.: "Role of Brain Insulin Receptor in Control of Body Weight and Reproduction", SCIENCE, vol. 22, 22 September 2000 (2000-09-22), pages 2122 - 2125, XP055499036 | Type: | Non-patent literature | Publication information: | KAHN ET AL.: "Loss of insulin signalling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction", MOLECULAR CELL, vol. 6, 2000, pages 87 - 97, XP055499037 | Type: | Non-patent literature | Publication information: | KITAMURA ET AL.: "Insulin Receptor Knockout Mice", ANNU. REV. PHYSIOL., vol. 65, 2003, pages 313 - 332, XP055499041 | DOI: | http://dx.doi.org/10.1146/annurev.physiol.65.092101.142540 | Type: | Non-patent literature | Publication information: | CORTEZ ET AL.: "Common mechanisms of PIKK regulation", DNA REPAIR, vol. 8, 2009, pages 1004 - 1008, XP026446528 | Type: | Non-patent literature | Publication information: | PICCALUGA ET AL.: "Imatinib mesylate in the treatment of hematologic malignancies", EXPERT OPIN. BIOL. THER., vol. 7, no. 10, 2007, pages 1597 - 1611, XP055499048 | DOI: | http://dx.doi.org/10.1517/14712598.7.10.1597 | Type: | Non-patent literature | Publication information: | MASS: "The HER receptor family: a rich target for therapeutic development", INT. J. RADIATION ONCOLOGY BIOL. PHYS., vol. 58, 2004, pages 932 - 940, XP008060823 | DOI: | http://dx.doi.org/10.1016/j.ijrobp.2003.09.093 | Type: | Non-patent literature | Publication information: | FABBRO ET AL.: "Protein kinases as targets for anticancer agents: from inhibitors to useful drugs", PHARMACOLOGY AND THERAPEUTICS, vol. 93, 2002, pages 79 - 98, XP002350189 | DOI: | http://dx.doi.org/10.1016/S0163-7258(02)00179-1 | Type: | Non-patent literature | Publication information: | FIAUD ET AL.: "Synthesis of Enantiopure 1-r-Aryl-2-c,5-t-diphenylphospholane oxides and boranes by Pd-Catalyzed C-P Bond Formation", EUR. J. ORG. CHEM., 2006, pages 650 - 656, XP055499101 | DOI: | http://dx.doi.org/10.1002/ejoc.200500577 | Type: | Non-patent literature | Publication information: | KAMER ET AL.: "Wide Bite Angle Diphosphines: Xantphos Ligands in Transition Metal Complexes and Catalysis", ACC. CHEM. RES., vol. 34, 2001, pages 895 - 904, XP055499103 |